Oculogica Inc.

New Richmond, WI · Founded 2013 · CIK 0001613810 · Medtech · Private

FDA-cleared eye-tracking devices for objective concussion diagnosis and sideline screening

oculogica.com →
Grants
$1.1M
3 awards
Sector median: 1
Raised
$22M
5 Form D · May 2024
28 months since last filing
Contracts
$2.2M
3 awards · Defense
#209 of 4531 in medtech
Patents
18
5 granted · 13 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$599,970
Private capital raisedForm D · SEC$1,689,998
Federal contractDepartment of Defense · Oculogica Eye Tracking System Eyeboxcns$75,350
Federal contractDepartment of Defense · Igf::ot::igf Oculogica Eye Tracking System Eyebox$163,000
Federal grantDepartment of Health and Human Services · Phase I · A software tool for objective identification of concussion-related vision disorders using a novel eye-tracking device$503,162
Federal grantDepartment of Health and Human Services · Phase I · A software tool for objective identification of concussion-related vision disorders using a novel eye-tracking device$553,162
Federal grantDepartment of Health and Human Services · Phase I · A software tool for objective identification of concussion-related vision disorders using a novel eye-tracking device$50,000
Private capital raisedForm D · SEC$8,071,764
Federal contractDepartment of Defense · Research And Development Proposal Titled A Highly Portable Device For Assessment Of Mild Traumatic Brain Injury In Deployed And Far-forward Settings From Broad Agency Announcement On Behalf Of Congressionally Directed Medical Research Programs$1,999,986
Private capital raisedForm D · SEC$4,048,963
Private capital raisedForm D · SEC$7,569,130
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
206ZYMO RESEARCH CORP.$2.3M—
207ZANSORS LLC$2.3M—
208BIOSURFACES INC$2.3M$900K
209Oculogica Inc.$2.2M$22M
210SAFETRACES, INC$2.2M$19M
211INNOVATIVE SURFACE TECHNOLOGIES INC$2.2M—
212Amprion, Inc.$2.2M$15M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 9 related persons
  • Jill EnosDirector
  • Jim FlanniganDirector
  • Jason HuangDirector
  • Bilal KhanDirector
  • Pratipatti LaxminarainDirector
  • Robert RitlopExecutive Officer
  • Rosina SamadaniDirector · Executive Officer
  • Uzma SamadaniDirector
  • Kathryn SwintekDirector

Patents

USPTO · 5 granted of 18

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.